Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids

American Journal of Clinical Nutrition

Volumn 64, Issue 5, 1996, Pages 748-756

  Clifford, Andrew J ^a   Ebeler, Susan E ^b   Ebeler, John D ^b   Bills, Nathan D ^b   Hinrichs, Steven H ^b   Teissedre, Pierre L ^b   Waterhouse, Andrew L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Amino acid based diet; cancer; catechin; transgenic mice; wine solids

Indexed keywords

DRINKING WATER; MEMBRANE LIPID;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; GENOTOXICITY; MOUSE; NONHUMAN; WINE;

ANIMALIA; MUS MUSCULUS;

EID: 0029964812     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/64.5.748     Document Type: Article

References (51)

1. Bailey GS, Williams DE. Potential mechanisms for food-related carcinogens and anticarcinogens. Food Technol 1993;47:105-18.
2. Willett WC. Diet and health: what should we eat? Science 1993;254:532-7.
3. Gronbeck M, Deis A, Sorensen TIA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995;310:1169-72.
4. Kato R, Nakadate T, Yamamoto S, Sugimura T. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 1983;4:1301-5.
5. Lesca P. Protective effects of ellagic acid and other plant phenols on benzo(a)pyrene-induced neoplasia in mice. Carcinogenesis 1983;4:1651-3.
6. Muhktar H, Das M, Khan WA, Wang ZY, Bik DP, Bickers DR. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 1988;48:2361-5.
7. Huang MT, Ferraro T. Phenolic compounds in food and cancer prevention. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: American Chemical Society, 1992:8-34.
8. Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP. Antitumor-promoting activities of hydrolyzable tannins in mouse skin. Carcinogenesis 1992;13:715-8.
9. Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int J Cancer 1992;51:425-32.
10. Pingzhang Y, Jinying Z, Shujun C, Hara Y, Qingfan Z, Zhengguo L. Experimental studies of the inhibitory effects of green tea catechin on mice large intestinal cancers induced by 1,2-dimethylhydrazine. Cancer Lett 1994;79:33-8.
11. Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 1995;95:221-5.
12. Macheix JJ, Sapis JC, Fleuriet A. Phenolic compounds and polyphenoloxidase in relation to browning in grapes and wines. Crit Rev Food Sci Nutr 1991;30:441-86.
13. Singleton VL. Naturally occurring food toxicants: phenolic substances of plant origin common in foods. Adv Food Res 1981;27:149-242.
14. Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
15. Osawa T. Phenolic antioxidants in dietary plants as mutagens. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: American Chemical Society, 1992:135-49.
16. Ito N, Hirose M, Shirai T. Carcinogenicity and modification of carcinogenic response by plant phenols. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: American Chemical Society, 1992:269-83.
17. Yoshizawa S, Horiuchi T, Suganuma M, et al. Penta-O-galloyl-β-D-glucose and (-)-epigallocatechin gallate: cancer preventive agents. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Washington, DC: American Chemical Society, 1992:316-25.
18. Kelloff GJ, Boone CW, Steele VE, et al. Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl 1994;20:1-24.
19. Pace-Asciak CR, Hahn S. Diamandis EP, Soleus G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;235:207-19.
20. Walzem RL, Clifford AJ. Folate deficiency in rats fed diets containing free amino acids or intact proteins. J Nutr 1988;118:1089-96.
21. Bills ND, Koury MJ, Dessypris EN, Clifford AJ. Ineffective hematopoiesis in folate-deficient mice. Blood 1992;79:2273-80.
22. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
23. Brinster RL, Chen HY, Trumbauer M, Senear AY, Warren R, Palmiter RD. Somatic expression of herpes thymidilate kinase in mice following injection of a fusion gene into eggs. Cell 1981;27:223-31.
24. Viney JL. Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev 1995;14:77-90.
25. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotrophic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987;237:1324-9.
26. Hinrichs SH, Nerenberg M, Reynolds RK, Khoury G, Jay G. A transgenic mouse model for human neurofibromatosis. Science 1987;237:1340-3.
27. Sergeyev AS. On the mutation rate of neurofibromatosis. Humangenetik 1975;28:129-38.
28. Baird AM, Green JE, Hinrichs SH. Animal models of human disease. Comp Pathol Bull 1992;24:3-4.
29. Thomas H, Balkwill F. Assessing new anti-tumor agents and strategies in oncogene transgenic mice. Cancer Metastasis Rev 1995;14:91-5.
30. Lamuela-Raventos RM, Waterhouse AL. A direct HPLC separation of wine phenolics. Am J Enol Vit 1994;45:1-5.
31. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-17.
32. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984;137:266-7.
33. Sanderson JH, Phillips CE. An atlas of laboratory animal haematology. Oxford, United Kingdom: Clarendon Press, 1981.
34. Alverdy JC, Aoys E, Moss GS. Effect of commercially available chemically defined liquid diets on the intestinal microflora and bacterial translocation from the gut. JPEN J Parenter Enteral Nutr 1990;14:1-6.
35. Rothman K, Garfinkel L, Keller AZ, Muir CS, Schotenfeld D. The proportion of cancer attributable to alcohol consumption. Prev Med 1980;9:174-9.
36. Bravo L, Abia R, Eastwood EA, Sara-Calixto F. Degradation of polyphenols (catechin and tannic acid) in the rat intestinal tract. Effect on colonic fermentation and fecal output. Br J Nutr 1994;71:933-46.
37. Hackett AM. The metabolism of flavonoid compounds in mammals. In: Cody V, Middleton E, Harborne JB, eds. Plant flavonoids in biology and medicine: biochemical, pharmacological and structure-activity relationships. New York: Alan R Liss, 1986:179-94.
38. Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin Biochem 1994;27:245-8.
39. Bell RH, Brinck-Johnsen T, Longnecker DS. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene. Pancreas 1991;4:475-8.
40. Dexter DL, Diamond M, Creveling J, Chen SF. Chemotherapy of mammary carcinomas arising in ras transgenic mice. Invest New Drugs 1993;11:161-8.
41. DeWille JW, Waddell K, Steinmeyer C, Farmer SJ. Dietary fat promotes mammary tumorigenesis in MMTV/v-Ha-ras transgenic mice. Cancer Lett 1993;69:59-66.
42. Porter GM, Armstrong L, Nielsen LL. Strategy for developing transgenic assays for screening antineoplastic drugs that affect tubilin polymerization. Lab Animal Sci 1995;45:145-50.
43. Bills ND, Hinrichs SH, Morgan R, Clifford AJ. Tissue folate levels in transgenic mice with tumors and in nontransgenic controls. J Natl Cancer Inst 1992;84:332-7.
44. Bills ND, Hinrichs SH, Birt DD. Tumor onset in HTLV-1 tax mice fed high-fat or calorie restricted diets. Fed Proc 1993;7:865(abstr).
45. Morioka N, Tsuchida T, Etoh T, Ishibashi Y, Otssuka F. A case of neurofibrosarcoma associated with neurofibromatosis: light microscopic, ultrastructural, immunohistochemical and biochemical investigations. J Dermatol 1990;17:312-6.
46. Tam AW, Darby JK, Riccardi VM. Expression of selected growth factors and oncogenes in neurofibrosarcomas complicating von Recklinghausen disease. Neurofibromatosis 1988;1:69-84.
47. Carroll KK. Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Res 1975;116:1130-2.
48. Klurfeld DM, Weber MM, Kritchevsky D. Inhibition of chemically induced mammary and colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Res 1987;47:2759-62.
49. Balentine DA. Manufacturing and chemistry of tea. In: Ho CT, Lee CY, Huang HT, eds. Phenolic compounds in food and their effects on health. Washington, DC: American Chemical Society, 1992:102-17.
50. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995;91:1182-8.
51. Schmidt DN. Apparent risk factors for chronic and acute pancreatitis in Stockholm County. Int J Pancreatol 1991;8:45-50.